GLOW blend (GHK-Cu + BPC-157 + TB-500): research, legal status and who sells it
This page is information, not medical advice. GLOW blend (GHK-Cu + BPC-157 + TB-500) is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- GLOW, GHK-Cu, BPC-157 and TB-500 blend
- Category
- Blend of GHK-Cu, BPC-157 and TB-500
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $0.464/mg to $2.07/mg, median $1.34/mg across 13 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | None of the three components is an FDA-approved drug, and no approved product combines them [1]. |
| United Kingdom | No UK-licensed medicine contains any of the three components [2][3][4]. |
| European Union | No medicine containing GHK-Cu, BPC-157 or TB-500 is authorized in the EU, according to EMA's central and Article 57 product data [5][6]. |
| Canada | No product containing GHK-Cu, BPC-157 or TB-500 appears in Health Canada's Drug Product Database [7]. |
| Australia | BPC-157 and TB-500 are Schedule 4 with Appendix D possession controls; GHK-Cu is not named, but the Poisons Standard lists copper compounds for human use in Schedule 4, except low-strength preparations [8]. |
| Sport (WADA) | BPC-157 (S0) and TB-500 (S2) are prohibited at all times; GHK-Cu is not named [9]. |
We haven't published a full overview of GLOW blend (GHK-Cu + BPC-157 + TB-500) yet. The legal status table and live prices on this page are current.
GLOW blend (GHK-Cu + BPC-157 + TB-500) prices: cheapest listings
The five lowest $/mg listings out of 18. See all GLOW blend (GHK-Cu + BPC-157 + TB-500) prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Bulk Peptide Supply | 57 | GLOW (BPC-157, TB500, GHK-CU) 10 mg/10 mg/ 50 mg | 70 mg | $33 | $0.464/mg | View | |
| Bulk Peptide Wholesale | 45 | GLOW (BPC-157, TB500, GHK-CU) 10mg/10mg/50mg 10 vials | 70 mg × 10 | $325 | $0.464/mg | View | |
| S1 Research | 50 | GLOW – GHK-CU 50mg/BPC-157 10mg/TB-500 10mg -70mg | 70 mg | $42 | $0.600/mg | View | |
| Alpha Peps | 78 | Glow Blend (BPC-157 / TB-500 / GHK-Cu 10/10/50mg) | 70 mg | $52 | $0.739/mg | View | |
| Bulk Peptide Supply | 57 | GLOW (BPC-157, TB500, GHK-CU) 10 mg/10 mg/ 50 mg (10 vials) | 70 mg × 10 | $550 | $0.786/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 14, 2026
- MHRA Products: licensed-medicine search for "ghk". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
- MHRA Products: licensed-medicine search for "bpc-157". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
- MHRA Products: licensed-medicine search for "thymosin". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 14, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 14, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 14, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 14, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 14, 2026